MedTrace Logo

Evaluation of Urinary Biomarkers Trend in Preterm Very Low Birth Weight Infants

NCT06781476 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2025-01-17

No results posted yet for this study

Summary

The purpose of this study is to define the temporal patterns of urinary biomarkers (CysC, EGF, KIM-1, NGAL, β2-Microglobulin, OPN, and MOD) in the first two weeks of life in preterm and/or very low birth weight (VLBW) infants in relation to the effect of specific factors (hsPDA, prenatal Doppler alterations) and drug therapies. Another objective is then to evaluate the predictivity of these biomarkers with respect to the occurrence of renal damage in preterm infants and possible cut-off values

Conditions

  • Kidney Injury

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Principal Investigators

  • Francesca Vitali, MD · IRCCS Azienda Ospedaliero-Universitaria di Bologna

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-07
Primary Completion
2025-06-15
Completion
2025-06-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06781476 on ClinicalTrials.gov